Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Loulergue

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Joint Bone Spine|November 2, 2013
Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for HealthVincent Goëb, Marc Ardizzone, Laurent Arnaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccinationOlivia Bonduelle, Nora Yahia, Sophie Siberil, et al.
The Lancet. Infectious Diseases|February 8, 2020
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled studySodiomon B Sirima, Laura Richert, Arnaud Chêne, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Joint Bone Spine|November 2, 2013
Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for HealthVincent Goëb, Marc Ardizzone, Laurent Arnaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccinationOlivia Bonduelle, Nora Yahia, Sophie Siberil, et al.
The Lancet. Infectious Diseases|February 8, 2020
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled studySodiomon B Sirima, Laura Richert, Arnaud Chêne, et al.
Pageof 7